Fox Chase Cancer Center

This study is testing a more flexible way to give the cancer drug cabozantinib to people with advanced kidney cancer or neuroendocrine tumors. The goal is to see if adjusting the dose up or down based on how patients feel can help them stay on treatment longer with fewer severe s…

This study is testing a two-part treatment for advanced bladder cancer that has spread. First, patients receive a combination of two drugs for about 4 months. If the cancer responds well, they then continue with just one of the drugs as a long-term 'maintenance' therapy for up to…

This is an early safety study to find the right dose of two drugs, neratinib and fam-trastuzumab deruxtecan, when given together. It's for adults with advanced stomach, esophageal, or other gastrointestinal cancers that have a specific marker called HER2 and have worsened after a…

This early-stage study is testing whether a more precise form of radiation therapy is safe and effective for people with advanced pancreatic cancer that cannot be removed by surgery. The goal is to see if this 'adaptive' radiation can better target the aggressive cancer cells whi…

This early-phase trial is testing whether a special type of radiation treatment can safely deliver higher doses to cancer that has spread to the abdomen or pelvis. The goal is to better control these tumors while keeping serious side effects low. The study will enroll about 30 ad…

This study is testing a more precise type of radiation therapy for men with intermediate-risk prostate cancer. The goal is to see if adjusting the radiation dose in real-time based on daily scans can better target the tumor while reducing damage to nearby organs like the bladder …

This early-stage study is testing whether giving extra, precisely targeted radiation after standard chemoradiation is safe and effective for rectal cancer. Researchers will use MRI scans every two weeks to adjust the extra radiation dose based on how the tumor responds, aiming to…

This study is testing whether a new combination of tests can better identify invasive bladder cancer before a patient has surgery to remove their bladder. Researchers will check if a special blood test and urine test, used alongside a standard scope exam, can accurately predict w…

This early-stage study is exploring whether taking CBD capsules can help prevent nerve damage (neuropathy) caused by a common chemotherapy drug called oxaliplatin. The trial will involve 30 people with colorectal cancer who are scheduled to receive oxaliplatin treatment. Particip…

This study is testing whether two new positive activities—helping around the house and contributing to the community—can improve the emotional well-being and quality of life for Asian American cancer patients. The goal is to help patients feel more independent, capable, and conne…

This international study aims to understand how breast and prostate cancer develop differently in people of African ancestry. Researchers will collect genetic data and health information from 1,500 Black cancer patients across 10 countries. The goal is to identify genetic pattern…